0      0


NWFT08 - The Current State of the 340B Program


‐ Jan 19, 2023 2:30pm

The 340B Drug Pricing Program is administered by the Office of Pharmacy Affairs (OPA) and requires drug manufacturers to provide front-end discounts on covered outpatient drugs purchased by covered entities. During this session we will provide an overall introduction to the 340B program and discuss key compliance and self-audit considerations. We will also address the management of contract pharmacy arrangements, 340B program administrators, and Health Center strategies related to manufacturer restrictions.

Speaker(s):